Total Payments
$9,834
2024 Payments
$3,123
Companies
51
Transactions
523
Medicare Patients
3,030
Medicare Billing
$320,203
Payment Breakdown by Category
Food & Beverage$9,834 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,834 | 523 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,159 | 52 | $0 (2024) |
| Novo Nordisk Inc | $1,007 | 56 | $0 (2024) |
| PFIZER INC. | $686.46 | 36 | $0 (2024) |
| GlaxoSmithKline, LLC. | $550.49 | 30 | $0 (2024) |
| Lilly USA, LLC | $515.75 | 29 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $434.54 | 23 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $414.96 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $404.36 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $399.80 | 20 | $0 (2024) |
| Amgen Inc. | $362.03 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,123 | 157 | ABBVIE INC. ($431.14) |
| 2023 | $2,264 | 117 | AbbVie Inc. ($266.96) |
| 2022 | $1,944 | 104 | ABBVIE INC. ($336.50) |
| 2021 | $830.53 | 45 | AbbVie Inc. ($124.27) |
| 2020 | $144.55 | 9 | PFIZER INC. ($44.92) |
| 2019 | $589.87 | 36 | Astellas Pharma US Inc ($94.05) |
| 2018 | $394.46 | 23 | Janssen Pharmaceuticals, Inc ($90.61) |
| 2017 | $543.65 | 32 | Merck Sharp & Dohme Corporation ($78.82) |
All Payment Transactions
523 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $10.85 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $9.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Cardio-renal | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: Inflammation | ||||||
| 12/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/03/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $32.25 | General |
| Category: Cardiovascular | ||||||
| 12/03/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: HIV | ||||||
| 12/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Diabetes Care | ||||||
| 11/13/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Hepatitis B Vaccine | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: RESPIRATORY | ||||||
| 11/05/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: HIV | ||||||
| 11/05/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.57 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Gastroenterology | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 872 | 1,418 | $267,780 | $99,574 |
| 2022 | 15 | 824 | 1,369 | $251,557 | $94,476 |
| 2021 | 10 | 605 | 1,086 | $185,340 | $71,921 |
| 2020 | 15 | 729 | 941 | $182,629 | $54,232 |
Total Patients
3,030
Total Services
4,814
Medicare Billing
$320,203
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 425 | $85,000 | $24,421 | 28.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 146 | 146 | $41,318 | $19,906 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 170 | $47,260 | $16,064 | 34.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 26 | 188 | $36,472 | $15,165 | 41.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 31 | 31 | $17,019 | $8,745 | 51.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 71 | 74 | $10,360 | $5,313 | 51.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 82 | $5,576 | $2,650 | 47.5% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 14 | 14 | $4,956 | $2,150 | 43.4% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 22 | 25 | $4,925 | $1,439 | 29.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 11 | 11 | $3,058 | $964.08 | 31.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 29 | 29 | $1,972 | $937.28 | 47.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 38 | 87 | $5,655 | $914.76 | 16.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 14 | 14 | $1,064 | $484.68 | 45.6% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 11 | 11 | $473.00 | $152.35 | 32.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 13 | 13 | $416.00 | $82.20 | 19.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 28 | 73 | $1,095 | $77.77 | 7.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 13 | 13 | $1,053 | $66.72 | 6.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 11 | 12 | $108.00 | $40.92 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 232 | 534 | $98,612 | $30,577 | 31.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 116 | 116 | $30,160 | $16,145 | 53.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 25 | 201 | $39,906 | $12,970 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 89 | $23,014 | $8,239 | 35.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 84 | 85 | $11,380 | $5,819 | 51.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 16 | 16 | $8,784 | $4,463 | 50.8% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 15 | 15 | $6,915 | $3,644 | 52.7% |
About Dr. Jonathan Younan, MD
Dr. Jonathan Younan, MD is a Emergency Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568405710.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Younan, MD has received a total of $9,834 in payments from pharmaceutical and medical device companies, with $3,123 received in 2024. These payments were reported across 523 transactions from 51 companies. The most common payment nature is "Food and Beverage" ($9,834).
As a Medicare-enrolled provider, Younan has provided services to 3,030 Medicare beneficiaries, totaling 4,814 services with total Medicare billing of $320,203. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Chicago, IL
- Active Since 06/14/2006
- Last Updated 03/07/2023
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1568405710
Products in Payments
- VRAYLAR (Drug) $732.14
- ELIQUIS (Drug) $556.48
- Kerendia (Drug) $434.54
- JARDIANCE (Drug) $428.50
- Ozempic (Drug) $426.85
- REXULTI (Drug) $381.11
- MOUNJARO (Drug) $306.87
- XARELTO (Drug) $287.01
- UBRELVY (Drug) $268.65
- ENTRESTO (Drug) $252.99
- Rybelsus (Drug) $240.28
- XIFAXAN (Drug) $220.62
- FARXIGA (Drug) $203.54
- Heplisav-B (Drug) $194.30
- TRELEGY ELLIPTA (Drug) $192.96
- VOQUEZNA (Drug) $189.37
- GEMTESA (Drug) $171.30
- SHINGRIX (Biological) $170.13
- MYRBETRIQ (Drug) $169.18
- PREVNAR 20 (Biological) $164.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Chicago
Dr. Barbara Bellar, M.d., J.d., Ma., Mph, M.D., J.D., MA., MPH
Emergency Medicine — Payments: $471,425
Emergency Medicine $471,425
Dr. Christopher Ross, Md, MD
Emergency Medicine — Payments: $338,465
Emergency Medicine $338,465
Janet Lin, M.d, M.D
Emergency Medicine — Payments: $118,644
Emergency Medicine $118,644
Michael Kurz
Emergency Medicine — Payments: $114,691
Emergency Medicine $114,691
Yanina Purim Shem Tov, M.d, M.D
Emergency Medicine — Payments: $90,220
Emergency Medicine $90,220
Pratik Mehta, Md, MD
Emergency Medicine — Payments: $74,561
Emergency Medicine $74,561